Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Genomic Valley Biotech Ltd - 539206 - Closure of Trading Window

 Pursuant to the Code of Conduct for Prevention of Insider Trading of the Company under SEBI(Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform you that the trading window for the purpose of trading in the securities of the Company by its Designated persons shall remain closed from October 01, 2022 till 48 (Forty Eight) hours after the conclusion of the Meeting of the Board of Directors of the Company to be held to consider and approve the Un-Audited Financial Results of the Company for the quarter and six months ended September 30, 2022.
28-09-2022
Bigul

Genomic Valley Biotech Ltd - 539206 - Intimation Of Extension Of Time For Holding Annual General Meeting (AGM)

 This is to inform you that pursuant to the provisions of Section 96(1) of the Companies Act, 2013, Genomic Valley Biotech Limited ('GVBL or the Company') has filed an application before Registrar of Companies, NCT of Delhi and Haryana (ROC) for an extension of holding Annual General Meeting (AGM) for the Financial Year 2021-22. The Registrar of Companies on receipt of application has approved the application on the reasons and circumstances stated therein and extended the date of Annual General Meeting (AGM) for three (3) Months. AGM Extension Approval granted by the Registrar of Companies is enclosed herewith. Please take the above on records.
26-08-2022
Bigul

Genomic Valley Biotech Ltd - 539206 - Intimation Of Extension Of Time For Holding Annual General Meeting (AGM)

 This is to inform you that pursuant to the provisions of Section 96(1) of the Companies Act, 2013, Genomic Valley Biotech Limited ('GVBL or the Company') has filed an application before Registrar of Companies, NCT of Delhi and Haryana (ROC) for an extension of holding Annual General Meeting (AGM) for the Financial Year 2021-22. The Registrar of Companies on receipt of application has approved the application on the reasons and circumstances stated therein and extended the date of Annual General Meeting (AGM) for three (3) Months. AGM Extension Approval granted by the Registrar of Companies is enclosed herewith. Please take the above on records.
26-08-2022
Bigul

Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to the applicable Regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and applicable provisions of the Companies Act, 2013, read with General Circular No.14/2020 dated 8th April, 2020, General Circular No.17/2020 dated 13th April, 2020, General Circular No.20/2020 dated 5th May, 2020 and General Circular No. 02/2021 dated January 13, 2021; General Circular No. 19/2021 dated December 08, 2021; General Circular No. 21/2021 dated December 14, 2021 and General Circular No. 02/2022 dated May 05, 2022 issued by the Ministry of Corporate Affairs, we hereby submitting the newspaper advertisement of Notice to shareholders to register their email IDs, Mobile Number and Bank Account Details.
27-07-2022
Bigul

Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to the Regulation 47 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copy of Newspaper advertisements of the Extract of Un-Audited Financial Results for the quarter and three months ended 30.06.2022 approved in Board Meeting of the Company held on 20.07.2022.
21-07-2022
Bigul

Genomic Valley Biotech Ltd - 539206 - Submission Of Un-Audited Financial Results For The Quarter And Three Months Ended 30Th June, 2022

 Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of Genomic Valley Biotech Limited ('Company') in its meeting held today approved the Un-Audited Financial Results (Standalone) for the Quarter and three months ended 30th June, 2022 of the Company as per Indian Accounting Standards (IND-AS) along with the Limited Review Report. Copy of the results along with the Limited Review Report of Statutory Auditors is attached herewith for your perusal.
20-07-2022
Bigul

Genomic Valley Biotech Ltd - 539206 - Board Meeting Outcome for Submission Of Outcomes Of Board Meeting And Un-Audited Financial Results For The Quarter And Three Months Ended 30Th June, 2022

 Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of Genomic Valley Biotech Limited ('Company') in its meeting held today approved the Un-Audited Financial Results (Standalone) for the Quarter and three months ended 30th June, 2022 of the Company as per Indian Accounting Standards (IND-AS) along with the Limited Review Report. Copy of the results along with the Limited Review Report of Statutory Auditors is attached herewith for your perusal.
20-07-2022
Bigul

Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Please find enclosed herewith the Newspaper Advertisements published for the Notice of Board Meeting to be held on 20th July, 2022, inter-alia, to consider and approve the Un-Audited Financial Results for the quarter and three months ended 30th June, 2022, in the newspapers, Financial Express (English Edition) and Jansatta (Hindi Edition) on 15th July, 2022.
15-07-2022
Bigul

Genomic Valley Biotech Ltd - 539206 - Closure of Trading Window

 In pursuant of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that a Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, the 20th July, 2022 at 11:00 A.M. inter-alia, to consider and approve the Un-Audited Financial Results for the quarter and three months ended 30th June, 2022. Pursuant to the Code of Conduct for Prevention of Insider Trading of the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform you that the trading window for the purpose of trading in the securities of the Company by its Designated persons has been closed from 01st July, 2022 till 48 hours of declaration of results i.e. 22nd July, 2022 (both days inclusive).
14-07-2022
Bigul

Genomic Valley Biotech Ltd - 539206 - Board Meeting Intimation for Considering And Approving Un-Audited Financial Results For The Quarter And Three Months Ended June 30, 2022

 Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/07/2022 ,inter alia, to consider and approve Un-Audited Financial Results for the quarter and three months ended June 30, 2022 .
14-07-2022
Next Page
Close

Let's Open Free Demat Account